BRAF and ameloblastoma: Within the conventional ameloblastomas, histological subtyping revealed the following for BRAF V600E immunoexpression: 32 cases (76.2%) of follicular ameloblastomas were positive; 3 cases (42.9%) of desmoplastic ameloblastomas were positive; and, for the plexiforme ameloblastomas, 3 cases (50.0%) were positive and 3 cases (50.0%) were negative.